INFLARX
InflaRx develops new therapeutics in the field of acute and chronic inflammation and consists of a team of internationally recognized researchers and clinicians who have dedicated their careers to translate discoveries and expertise into new therapeutic concepts for clinical application. In April 2018, InflaRx conducted a USD 117 million total gross proceeds follow-on transaction on the US Nasdaq global select market comprised of a primary component of USD 63 million investment into InflaRx as well as a secondary component of USD 54 million to existing first-day shareholders of InflaRx. InflaRx was founded in December 2017 and is headquartered in Jena, Germany.
INFLARX
Social Links:
Industry:
Health Care Medical Pharmaceutical Therapeutics
Founded:
2007-12-01
Address:
Jena, Thuringen, Germany
Country:
Germany
Website Url:
http://www.inflarx.de
Total Employee:
11+
Status:
Active
Contact:
+49 (0)3641 508 180
Email Addresses:
[email protected]
Total Funding:
214.83 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Apache Nginx Microsoft Exchange Online Office 365 Mail
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
Auris Medical
Auris Medical develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
VetSource
VetSource is a pharmaceuticals company providing pet care medication and vaccination services.
Current Employees Featured
Founder
Stock Details
Investors List
Federal Ministry of Health
Federal Ministry of Health investment in Grant - InflaRx
German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF) investment in Grant - InflaRx
Cormorant Asset Management
Cormorant Asset Management investment in Series D - InflaRx
RA Capital Management
RA Capital Management investment in Series D - InflaRx
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series D - InflaRx
Staidson Hongkong Investment
Staidson Hongkong Investment investment in Series C - InflaRx
bm-t beteiligungsmanagement thuringen
bm-t beteiligungsmanagement thuringen investment in Series B - InflaRx
Affentranger Associates
Affentranger Associates investment in Series A - InflaRx
bm-t beteiligungsmanagement thuringen
bm-t beteiligungsmanagement thuringen investment in Seed Round - InflaRx
Affentranger Associates
Affentranger Associates investment in Seed Round - InflaRx
Official Site Inspections
http://www.inflarx.de Semrush global rank: 4.18 M Semrush visits lastest month: 2.84 K
- Host name: 85.215.36.174
- IP address: 85.215.36.174
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
